Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Nateglinide & Type 2 diabetes (T2D), nateglinide has received approval from both the FDA and the EMA for treating Type 2 diabetes (T2D). However, its current use is more restricted, mainly serving as an additional treatment when diet, exercise, and metformin do not suffice. According to the FDA label, it can be used as monotherapy or in combination with metformin for patients with T2D whose hyperglycemia is not adequately managed by diet and exercise alone.
It is approved by the EMA for treati…